The Indian Journal of Pediatrics

, Volume 63, Issue 5, pp 615–632 | Cite as

Nutrition and HIV infection in children

  • E. E. Mannick
  • J. N. Udall
  • M. Kaiser
  • G. Fuchs
  • R. Suskind
Special Article


HIV infection has profound effects on a patient’s nutritional status because it can modulate appetite, nutrient absorption and basal metabolic rate. In addition, HIV infection can lead to the depletion of a variety of vitamins and micronutrients including vitamins A, D, B2, B6, B12, L-carnitine, iron, zinc and selenium. This review article summarizes existing data regarding nutritional defects in HIV-infected patients and the results of clinical studies addressing the effects of nutritional supplementation in infected patients.

Key words

HIV infection Basal metabolic rate Micronutrients Nutritional defects 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mann J. (Ed.),AIDS and the World. Cambridge, MA: Harvard University Press, 1992.Google Scholar
  2. 2.
    Miiler TL, Evans S, Orav EJet al. Growth and body composition in children with human immunodeficiency virus-1 infection.Am J Clin Nutr 1993; 57: 588–592.Google Scholar
  3. 3.
    Halsey NA, Boulos R, Holt E, Ruff Aet al. Transmission of HIV-infection from mothers to infants in Haiti.J Am Med Assoc 1990; 264: 2088–2092.CrossRefGoogle Scholar
  4. 4.
    Henderson RA, Saavedra JM, Yolken RH, Perman JA. Nutritional management of HIV infection in childhood.Annalés Nestlé 1993; 51: 87–97.Google Scholar
  5. 5.
    Kuvibidila S, Warner R, Suskind Det al Nutritional status of hemophiliacs with and without infection with the human immunodeficiency virus (HIV).Nutr Res 1989; 9: 1197–1206.CrossRefGoogle Scholar
  6. 6.
    Keusch GT, Thea DM. Malnutrition in AIDS.Med Clin North Am 1993;77: 795–814.PubMedGoogle Scholar
  7. 7.
    Moldawer LL, Georgieff M, Lundholm K. Interleukin 1 tumour necrosis factoralpha (cachèctin) and the pathogenesis of cancer cachexia.Clin Physiol 1987; 7: 263–274.PubMedGoogle Scholar
  8. 8.
    Kern KA, Norton JA. Cancer cachexia.J Parenter Enterai Nutr 1988; 12: 286–298.Google Scholar
  9. 9.
    LoPresti JS, Fried JC, Spencer CA, Niceloft JT. Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS)Ann Intern Med 1989; 110: 970–975.PubMedGoogle Scholar
  10. 10.
    Hellerstein MK. Pathophysiology of lean body wasting and nutrient unresponsiveness in HIV/AIDS: Therapeutic implications. In:Nutrition and HIV/AIDS, Vol. 1, Chicago: PAAC Publishing Inc, 1992: 17–25.Google Scholar
  11. 11.
    Brettler DB, Forsberg A, Bolivar Eet al. Growth failure as a prognostic indicator for progression to acquired immunodeficiency syndrome in children with hemophilia.J Pediatr 1990; 117: 584–588.PubMedCrossRefGoogle Scholar
  12. 12.
    Suskind D.Nutrition and malnutrition in HIV positive infants. Physiology Student Research Day, LSU Medical Centre, New Orleans, LA, October 8, 1994.Google Scholar
  13. 13.
    Nsanga B, Ryder R, Nsuami Met al. High HIV-associated infant mortality correlates with poorpost-partum maternal health: 18 months followup of 477 children (CH) born to HIV(+) mothers (MO) in Zaire. In:Proceedings of the Fifth International Conference on AIDS, Montreal, June 4–9, 1989. Ottowa, Ont: International Development Research Centre, 1989: 324 (abstract).Google Scholar
  14. 14.
    The DM, St.Louis ME, Atido Uet al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infantsN Engl J Med 1993; 3291: 696–702.Google Scholar
  15. 15.
    Miller TL, Orav EJ, Martin SRet al. Malnutrition and carbohydrate malabsorption in children with vertically transmitted human immunodeficiency virus 1 infection.Gastroenterol 1991; 100: l296–1302.Google Scholar
  16. 16.
    Italian Pediatric Intestinal/HIV Study Group. Intestinal malabsorption of HIV infected children: Relationship to diarrhea, failure to thrive, enteric microorganisms and immune impairment.AIDS 1993; 7: 1435–1440.Google Scholar
  17. 17.
    Kotier DP, Gaetz HP, Lange Met al. Enteropathy associated with the acquired immumodeficiency syndrome.Ann Intern Med 1984; 101: 421–447.Google Scholar
  18. 18.
    Pediatric HIV Forum, Vol. 1, no. 2, Nov. 1993.Google Scholar
  19. 19.
    Wanke CA. Diarrhea and enterai complications of AIDS. In:Hyperalimentation: A practical approach. Advanced in Nutritional and Metabolic support, Sept 21, 23, 1994, Boston, MA.Google Scholar
  20. 20.
    Greenson JK, Belitsos PC, Yardley JH, Bartlett JG. AIDS enteropathy: Occult enteric infections and duodenal mucosal alterations in chronic diarrhoea.Ann Intern Med 1991; 114: 366–372.PubMedGoogle Scholar
  21. 21.
    Keusch GT, The DM, Kamenga Met al. Persistent diarrhea associated with AIDS.Acta Paediatr Suppl 1992; 381: 45–48.PubMedGoogle Scholar
  22. 22.
    McGowan I, Hawkins AS, Weller IVD. The natural history of cryptosporidial diarrhea in HIV-infected patients.AIDS 1993; 7: 349–354.PubMedCrossRefGoogle Scholar
  23. 23.
    Scaglia M, Atzori C, Marchetti COet al. Effectiveness of aminosidine (parrhomycin) sulfate in chronic cryptasporidium diarrhea in AIDS patients: An odpen, uncontrolled, prospective clinical trial.JID 1994, 170: 1349–1350.PubMedGoogle Scholar
  24. 24.
    Clezy K, Gold J, Blaze J, Jones P. Paromomycin for the treatment of cryptosporidial diarrhea in AIDS patients.AIDS 1991, 5: 1146–1147.PubMedGoogle Scholar
  25. 25.
    Kanyok TP, Novak RM, Danziger LH, Preliminary results of a randomized blinded, control study of paromomycin vs. placebo for the treatment of cryptosporidium diarrhea in AIDS patients [abstract PoBIO-1508]. In:Program and Abstracts: IX International Conference on AIDS (Berlin): London: Wellcome Foundation, 1993.Google Scholar
  26. 26.
    Fennoy I, LeungJ. Refeeding and subsequent growth in the child with AIDS.Nutr Clin Prac 1990; 5: 54–58.Google Scholar
  27. 27.
    Miller TL, Awnetwant EL, Evans Set al Gastrostomy tube supplementation for HIV-infected children (submitted).Google Scholar
  28. 28.
    Kotier D, Tierney A, Ferraro Ret al Enteral alimentation and repletion of body cell mass in malnourished patients with the acquired immuno-deficiency syndrome.Am J Clin Nutr 1991; 53: 149–154.Google Scholar
  29. 29.
    Kotler DP, Tierney AR, Culpepper-Morgan JAet al. Effect of home total parenteral nutrition upon body composition in patients with acquired immunodeficiency syndrome.J Parenter Enter Nutr 1990; 14: 454–458.Google Scholar
  30. 30.
    Kotier DP, Tierney AR, Altilio Det al. Body mass repletion during gancyclovir treatment of cy tomegalovirus infection in patients with acquired immumodeficiency syndrome.Arch Intern Med 1989; 149: 901–905.CrossRefGoogle Scholar
  31. 31.
    Gotschilich MM, Jenkins M, Warden GDet al. Differential effects of three different enterai dietary regimens on selected outcome variables in burn patients. JPEN 1990; 14: 225–236.Google Scholar
  32. 32.
    Daly JM, Lieberman MD, Goldfine Jet al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, and clinical outcome.Surg 1992; 112: 56–67.Google Scholar
  33. 33.
    Chlebowski RT, Beall G, Grosvenor Met al. Long-term effects of early nutritional support with new enterotropic peptidebased formula vs. standard enterai formula, in HIV-infected, patients: randomized prospective trial.Nutrition 1993; 9: 507–512.PubMedGoogle Scholar
  34. 34.
    Blackburn GL, Bell S. Eutrophia in patients with HIV infection and early AIDS with novel nutrient “cocktail”: Is this the first food for special medical purpose?,Nutrition 1993; 9: 554–556.PubMedGoogle Scholar
  35. 35.
    Winter H. Proposed recommendations for nutritional support of pediatric HIV patient, (unpublished data).Google Scholar
  36. 36.
    Bell SJ, Mascioli EA, Forse RAet al. Nutrition support and the human immunodeficiency virus (HIV).Parasitology 1993; 107 (suppl): S53-S67.PubMedCrossRefGoogle Scholar
  37. 37.
    Semba RD, Muhilal Scott, ALet al. Depressed immune response to tetanus in children with vitamin A deficiency.J Nuttr 1992; 122: 101–107.Google Scholar
  38. 38.
    Pasatiempo AMG, Abaza M, Taylor CEet al. Effects of timing and dose of vitamin A on tissue retinol concentrations and antibody production in the previously vitamin A-depleted rats.Am J Clin Nutr 1992; 55: 443–451.PubMedGoogle Scholar
  39. 39.
    Wolbach SB, Howe PR. Tissue changes following deprivation of fat-soluble A vitamin.J Exp Med 1925; 42: 753–778.CrossRefPubMedGoogle Scholar
  40. 40.
    Moriguchi S, Jackson JC, Watson RR. Effects of retinoids on human lymphocyte functionin vitro.Human Toxicol 1985; 4: 365–378.Google Scholar
  41. 41.
    Abb J, Deinhardt F. Effects of retinoic acid on the human lymphocyte response to nitrogens.Exp Cell Biol 1980; 48: 168–179.Google Scholar
  42. 42.
    Fuller C, Faulkner H, Bendich Aet al. Effect of B-carotene supplementation on phctosuppression of delayed type hypersensitivity in normal young men.Am J Clin Nutr 1992; 56: 684–690.PubMedGoogle Scholar
  43. 43.
    Dresser DW. Adjuvanticity of vitamin A.Nature 1968; 217: 527–629.PubMedCrossRefGoogle Scholar
  44. 44.
    Alexaner M, Newmark H, Miller G. Oral beta-carotene can increase the number of OKT4 positive cells in human blood.Immunology Lett 1985; 9: 221–224.CrossRefGoogle Scholar
  45. 45.
    Semba RD, Muhilal, Ward BJet al. Altered T cell subset proportions in vitamin A deficient childrenLancet 1993; 341: 5–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Sommer A, Tarwotjo I, Djuinaedi Eet al. Impact of vitamin A supplementation on child mortality: A randomized community trial.Lancet 1986; 1: 1169–1173.PubMedCrossRefGoogle Scholar
  47. 47.
    Coutsoudis A, Broughton M, Coovadia HN. Vitamin A supplementation reduces measles morbidity in young African children: a randomized, placebo-controlled, double blind trial.Am J Clin Nutr 1991; 54: 890–895.PubMedGoogle Scholar
  48. 48.
    Fawzi WW, Chalmers TC, Herrera MG, Mosteller F. Vitamin A supplementation and child mortality: A meta-analysisJAMA 1993; 269: 898–903.PubMedCrossRefGoogle Scholar
  49. 49.
    Beach RS, Mantero-Atienza E, Shor-Posner Get al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992; 6: 701–708.PubMedCrossRefGoogle Scholar
  50. 50.
    Bogden JD. Baker H, Rank Oet al. Micronutrient status and human immunodeficiency virus (HIV) infection.Ann NY Acade Sci 1990; 587: 189–195.Google Scholar
  51. 51.
    Coodley GO, Coodley MK, Nelson HD, Loveless MO. Micronutrient concentrations, in the HIV wasting syndrome.AIDS 1993; 7: 1595–1600.PubMedGoogle Scholar
  52. 52.
    Tang AM, Graham NMH, Kirby AJet al. Dietary micronutrient intake and risk of progression to acquired immuno-deficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-l)-infected homosexual men.Am J Epidemiol 1993; 138: 937–951.PubMedGoogle Scholar
  53. 53.
    Garewal HS, Ampel NM, Watson RRet al. A preliminary trial of beta-carotene in subjects infected with the human immuno-deficiency virus.J Nutr 1992; 122(uppl: 728–732.PubMedGoogle Scholar
  54. 54.
    Coodley G, Nelson HD, Loveless MO, Folk C. Beta carotene in HIV infection.Journal of Acquired Immune Deficiency Syndrome 1993; 6: 272–276.Google Scholar
  55. 55.
    Murata T, Tamai H, Morinobu Tet al. Effect of long-term administration of β-earotene on lymphocyte subsets in humans.Am J Clin Nutr 1994; 60: 597–602.PubMedGoogle Scholar
  56. 56.
    Semba DR, Miotti PG, Chiphangwi JDet al. Maternal vitamin A deficiency and motherto-child transmission of HIV-1lancet 1994; 343: 1593–1597.PubMedCrossRefGoogle Scholar
  57. 57.
    Locardi C, Petrini C, Boccoli Get al. Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon invitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production.J Virol 1990; 64: 5874–5882.PubMedGoogle Scholar
  58. 58.
    Skolnick PR, Jahn B, Wang MZet al. Enhancement of human immunodeficiency virus replication in monocytes by 1,25 dihydroxycholecalciferol.Proc Natl Acad Sci 1991; 88: 6632–6636.CrossRefGoogle Scholar
  59. 59.
    Schuitemaker H, Kootstra NA, Koppelman MHGMet al. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages.J Clin Invest 1992; 89: 1154–1160.PubMedGoogle Scholar
  60. 60.
    Bermudez LE, Young LS, Gupta S. 1,25 dihyroxyvitamin D3-dependent inhibition of growth or killing of Mycobacterium avium complex in human macrophages is mediated by TNF and GM-CSF.Cell Immunol 1990; 127: 432–441.PubMedCrossRefGoogle Scholar
  61. 61.
    Haug C, Muller F, Aukrust P, Froland SS. Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: Correlation with degree of immunodeficiency and survival.J Inf Dis 1994, 169: 889–893.Google Scholar
  62. 62.
    Kline K, Rao A, Romach E, Kidao S, Morgan TJ, Sander BG. Vitamin E effects on retrovirus-induced immune dysfunction.Ann NY Acad Sci 1990; 587: 294–296.Google Scholar
  63. 63.
    Gogu SR, Beckman BS, Rangan SRS, Agrawal KC. Increased therapeutic efficacy of Ziovudine in combination with vitamin E.Biochem Biophys ResCommun 1989; 165: 401–407.PubMedCrossRefGoogle Scholar
  64. 64.
    Meydani SN, Ribaya-Mercado JD, Russell RMet al. Vitamin B6 deficiency impairs interleukin-2 production and lymphocyte proliferation in elderly adults.Am J Clin Nutr 1991; 53: 1275–1280.PubMedGoogle Scholar
  65. 65.
    Axelrod AE, Trakatellis AC, Bloch H, Stienbring WR. Effects of pyridoxine deficiency upon delayed hypersensitivity in guinea pigs.J Nutr 1963; 79: 161–167.PubMedGoogle Scholar
  66. 66.
    Axelrod AE, Traktellis AC. Induction of tolerance to skin homografts by administering splenic cells to pyridoxinedeficient mice.Proc Soc Exp Biol Med 1964; 116: 206–210.PubMedGoogle Scholar
  67. 67.
    Hodges REJ Beam WB; Ohlson MA;. Bleiler RE. Factors affecting human antibody response IV. Pyridoxine deficiency.Am J Clin Nutr 1962; 11: 180–186.PubMedGoogle Scholar
  68. 68.
    Talbott MC, Miller LT, Kerkvliet NI. Pyridoxine supplementation: effect oh lymphocyte responses in elderly persons.Am I Clin Nutr 1987; 46: 659–664.Google Scholar
  69. 69.
    Baum MK, Mantero-Atienza E, Shor-Posner Get al. Association of vitamin B6 status with parameters of immune function in early HIV-1 infection.J Acquire Immune Defic Syndr 1991; 4: 1122–1132.Google Scholar
  70. 70.
    Mantero-Atienza E, Baum M, Beach Ret al. Vitamin B6 and immune function in HIV infection. Sixth Int Conf on AIDS, San Francisco, June 21–24, 1990, Abstract 3123.Google Scholar
  71. 71.
    Remacha AF, Riera A, Cadafalch J, Gimferrer E. Vitamin B-12 abnormalities in HIV-infected patients.Eur J Haematol 1991; 47: 60–64.PubMedCrossRefGoogle Scholar
  72. 72.
    Burkes RL, Cohen H, Krailo M, Sinow RM, Carmel R. Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders.Eur J Haematol 1987; 38: 141–147.PubMedCrossRefGoogle Scholar
  73. 73.
    Harriman GR, Smith PD, Horne MKet al. Vitamin B12 malabsorption in patients with acquired immuno-deficiency syndrome.Arch Intern Med 1989; 149: 2039–2041.PubMedCrossRefGoogle Scholar
  74. 74.
    Herbert V, Fong W, Guile V, Stopler T. Low holtranscobalamin II is the earliest serum marker for subnormal vitamin B12 (cobalamin) absorption in patients with AIDS.Am J Hematol 1990; 34: 132–139.PubMedCrossRefGoogle Scholar
  75. 75.
    Kubota K, Arai T, Tamura J, Shirakua T, Mouta T. Restoration of decreased supressor cells by vitamin B12 therapy in a patient with pernicious ranemia.Am JHematol 1987; 24: 221–223.PubMedCrossRefGoogle Scholar
  76. 76.
    Kubota K, Kurabayaski H, Kawada Eet al. Restoration of abnormally high CD4/CD8 ratio and low natural killer celll activity by vitamin B12 therapy in a patient with post gastrectomy megaloblastic anemia,Int Med 1992; 31: 125–126.Google Scholar
  77. 77.
    Baum MK, Beach R, Mantero-Atienzaet al. Predictors of change in immune function: Longitudinal analysis of nutritional and immune status in early HIV-1 infection.Int Conf AIDS, 1991; 7: 329 (abstract no M.C. 3127).Google Scholar
  78. 78.
    Beach RS, Morgan R, Wilkie Fet al. Plasma Vitamin B12 levels as a potential cofactor in studies of human immunodeficiency virus type I-related cognitive changes.Arch Nuerol 1992; 49: 501–506.Google Scholar
  79. 79.
    Trimble KC, Goggins MG, Molloy AMet al. vitamin B12 deficiency is not a cause of HIV-associated neuropathy.AIDS 1993; 7: 1132–1133.PubMedCrossRefGoogle Scholar
  80. 80.
    Ameisen JC. Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer.AIDS 1994; 8: 1197–1213.PubMedGoogle Scholar
  81. 81.
    Morgan AC. Regulation of apoptosis for therapeutic benefit. In:Apoptosis: Exploiting Cell Death for Therapeutic Application, IBC’s International Conference, November 5–6, 1994, Boston, MA.Google Scholar
  82. 82.
    Lake-Bakaar G, Quadros E, Beidas Set al. Gastric secretory failure in patients with the Acquired immunodeficiency Syndrome (AIDS).Ann Int Med 1988; 502–504.Google Scholar
  83. 83.
    Herzlich BC, Schiano TD, Moussa Zet al. Decreased intrinsic factor secretion in AIDS: Relation to parietal cell acid secretory capacity and vitamin B12 malabsorption.Am J Gastroeneterol 1992; 87: 1781–1788.Google Scholar
  84. 84.
    Kotier DP, Gaetz HP, Lange Met al. Enteropathy associated with the acquired immunodeficiency syndrome.Ann Intern Med 1984; 101: 421–428.Google Scholar
  85. 85.
    Boudes P, Zittoun J, Sobel A. Folate. Vitamin B12 and HIV infection.Lancet 1990; 335: 1401–1402.PubMedCrossRefGoogle Scholar
  86. 86.
    Herbert V, Jacobson J, Colman Net al. Negative folate balance in AIDS.FASEB J 1989; 3: A1278.Google Scholar
  87. 87.
    Surtees R, Hyland K, Smith I. Central Nervous system methyl group metabolism in children with neurological complications of HIV infection.Lancet 1990; 335: 629–621.CrossRefGoogle Scholar
  88. 88.
    McKinsey DS, Furfee D, Kurtin PJ. Megaloblastic pancytopenia associated with dapsone and trimethoprim treatment of Pneumocystics carinii pneumonia in the acquired immunodeficiency syndrome.Arch Intern Med 1989; 149: 965.PubMedCrossRefGoogle Scholar
  89. 89.
    Sattler FR, Allegra GJ, Verdegem TDet al. Trimetrexate-Ieucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumonia.J Infect Dis 1990; 161: 91–96.PubMedGoogle Scholar
  90. 90.
    Hollander H. Leukopenia, trimethoprimsulfamethoxazole and folic acid (letter).Ann Intern Med 1985; 102: 138.PubMedGoogle Scholar
  91. 91.
    Bygbjerg IC, Lund JT, Harding M. Effect of folic and folinic acid on cytopenia occurring during co-trimoxazole treatment of Pneumocystis carinii pneumonia.Scand J Infect Dis 1988; 20: 685–686.PubMedGoogle Scholar
  92. 92.
    Saferin S, Lee BL, Sande MA. Adjunctive folinic acid with trimethoprin sulfamethoxazole for pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death.Infect Dis 1994; 170: 912–917.Google Scholar
  93. 93.
    Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells.Nature 1987; 326: 711–713.PubMedCrossRefGoogle Scholar
  94. 94.
    Schreck R, Rieber P, Baeuerle P. Activation of NF-kB by oxidant stress.EMBO J 1991; : 2247–2258.Google Scholar
  95. 95.
    DeQuay B, Malinverni R, Lauterburg B. Glutathione depletion in HIV infected patients: Role of cysteine deficiency and effect of oral N-acetyl cysteine.AIDS 1992; 6: 815–819.CrossRefGoogle Scholar
  96. 96.
    Staal FJT, Roederer M, Israelski DMet al. Inlracellular glutathione levels in T-cell subsets decreased in HlV-infected inviduals.Aids Res Retrovir 1992; 8: 305–311.Google Scholar
  97. 97.
    Harakeh S, Niedzwiecki A, Jariwalla RJ. Mechanistic aspects of ascorbate inhibition of human immumodeficiency virus.Chem Bio Interact 1994; 8: 207–215.CrossRefGoogle Scholar
  98. 98.
    DeSimone C, Famularo G, Tzantzoglou S, Trinchieri V, Moretti S, Sorice F. Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS. Effect of oral L-carnitine.AIDS 1994; 8: 655–660.CrossRefGoogle Scholar
  99. 99.
    Beck KW, Schramel P, Hedl A, Jaeger H, Kaboth W. Serum trace element levels in HIV-infected subjects.Biological Trace Element Research 1990; 25.: 89–96.PubMedGoogle Scholar
  100. 100.
    Blumberg BS, Hann HWL, Mildvan D,et al. Iron and iron binding proteins in persistent generalized lymphadenopthy and AIDS (letter).Lancet 1984; 1; 347.PubMedCrossRefGoogle Scholar
  101. 101.
    FAbris N, Mocchegiani E, Galli Met al. AIDS, zinc deficiency and thymic hormone failure (letter).AMA 1988; 259: 839–840.Google Scholar
  102. 102.
    Falutz J, Tsoukas C, Gold P. Zinc as a cofactor in human immuno-deficiency virus-induced immunosuppression. JAMA 1988; 259: 2850–2851.PubMedCrossRefGoogle Scholar
  103. 103.
    Tong TK, Andrew LR, Albert A, Mickell JJ. Childhood acquired immune deficiency syndrome manifesting as acrodermatitis enteropathica.J Pediatr 1986; 108: 426–428.PubMedCrossRefGoogle Scholar
  104. 104.
    Caselli M, Bicocchi R. Taux seriques du zinch che les malades atteint du syndrome d’immunodieficit acquis [Serum zinc levels in patients with the acquired immunodeficiency syndrome] (letter).Presse Md year; 15: 1877.Google Scholar
  105. 105.
    Graham NMH, Sorensen D, Odaka Net al. Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS.J Acquire immun Defic Syndr 1991, 4: 976–980.Google Scholar
  106. 106.
    Reich EN, Church JA. Oral zinc supplementation in the treatment of HIV-infected children.Pediatrie AIDS and HIV Infection: Feotus to Adolescent 1994; 5: 357–360.Google Scholar
  107. 107.
    Dworkin BM, Rosenthal WS, Wormser GP, Weiss L. Selenium deficiency in the acquired immuno-deficiency syndrome.J Parenteral Enterai Nutr 1986; 10: 405–407.Google Scholar
  108. 108.
    CirelIi A, Ciardi M, DeSimone Cet al. Serum selenium concentration and disease progress in patients with HIV infection.Clin Biochem 1999; 24: 2211–2214.Google Scholar
  109. 109.
    Mantero-Atienza E, Beach RS, Gavancho MCet al. Selenium Status of HIV-1 infected individuals.J Parenter Enterai Nutr 1991; 15: 693–694.Google Scholar
  110. 110.
    Dworkin BM, Antonecchia PP, Smith Fet al. Reduced cardiac selenium content in the acquired immunodeficiency syndrome.J Parenter Enteral Nutr1989; 13: 644–647.CrossRefGoogle Scholar
  111. 111.
    Zazzo JF, Chalas J, LaFont Aet al. Is nonobstructive cardiomyopathy in AIDS a selenium deficiency-related disease?J Parenteral Enterai Nutr 1988; 12: 537–538.Google Scholar
  112. 112.
    Schrauzer GN, Sacher J. Selenium in the maintenance and therapy of HIV-infected patients ChemBiol Interact 1994; 91: 199–205.CrossRefGoogle Scholar
  113. 113.
    Van de Perre P, Simonon A, Msellati Pet al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant: A prospective cohort study in Kigali, Rwanda.N Engl J Med 1991; 325: 593–598.PubMedCrossRefGoogle Scholar
  114. 114.
    Dunn D, Newell M-L, Ades A, Peckham CS. Risk of human immuno-deficiency virus type 2 transmission through breastfeeding.Lancet 1992; 340: 585–588.PubMedCrossRefGoogle Scholar
  115. 115.
    World Halth Organization HIV transmission and breastfeedingBull World Health Org. 1992; 70: 667–669.Google Scholar
  116. 116.
    Peckham: CS. Human immuno-deficiency virus infection and pregnancy.Sex Transm Dis 1994,-21 (2 suppl): S28-S31.Google Scholar
  117. 117.
    Connor EM, Sperling RS, Belber Ret al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment.NEJM 1994; 18: 1173–1180.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 1996

Authors and Affiliations

  • E. E. Mannick
    • 1
  • J. N. Udall
    • 1
  • M. Kaiser
    • 1
  • G. Fuchs
    • 1
  • R. Suskind
    • 1
  1. 1.Department of PediatricsLSU Medical CenterNew OrleansUSA

Personalised recommendations